Effect and mechanism of human umbilical cord mesenchymal stem cells on preventing murine acute graft-versus-host disease

Tao HONG; Rui WANG; Xiaoqi WANG; Weihao WANG; Yuxuan DU; Yundi HE; Chao MA; Huihui AN; Junjie WANG; Yunfang ZHANG; Qiangguo GAO; Shijie YANG; Xi ZHANG

doi:10.16016/j.1000-5404.202108059

您当前的位置：

首页 >

文章列表页 >

Effect and mechanism of human umbilical cord mesenchymal stem cells on preventing murine acute graft-versus-host disease

Monographic Reports: Basic and clinical research on complications after hematopoietic stem cell transplantation | 更新时间：2026-01-09

- Effect and mechanism of human umbilical cord mesenchymal stem cells on preventing murine acute graft-versus-host disease
- Journal of Third Military Medical University Vol. 43, Issue 21, Pages: 2276-2285(2021)
- 作者机构：
  
  1.400037 重庆，陆军军医大学(第三军医大学)第二附属医院血液病医学中心，全军血液病中心，创伤、烧伤与复合伤国家重点实验室
  2.563099 贵州遵义，遵义医科大学第二附属医院检验科
  3.400038 重庆，陆军军医大学(第三军医大学)基础医学院细胞生物学教研室
- 作者简介：
- 基金信息：
  
  the Key Special Project of National Key R & D Program(2017YFA0105502);the 2020 Open Project of National Clinical Medicine Research Center for Hematological System Diseases(2020ZKZC02)
- DOI：10.16016/j.1000-5404.202108059
  CLC： R392.8;R617;R733.7
- Received：10 August 2021，
  
  Revised：2021-09-22，
  
  Published：15 November 2021
- 稿件说明：
移动端阅览
Tao HONG, Rui WANG, Xiaoqi WANG, et al. Effect and mechanism of human umbilical cord mesenchymal stem cells on preventing murine acute graft-versus-host disease[J]. Journal of Third Military Medical University, 2021, 43(21): 2276-2285.
DOI：

Tao HONG, Rui WANG, Xiaoqi WANG, et al. Effect and mechanism of human umbilical cord mesenchymal stem cells on preventing murine acute graft-versus-host disease[J]. Journal of Third Military Medical University, 2021, 43(21): 2276-2285. DOI： 10.16016/j.1000-5404.202108059.

摘要

目的

探讨人脐带间充质干细胞(human umbilical cord mesenchymal stem cells

HUCMSCs)对小鼠急性移植物抗宿主病(acute graft-versus-host disease

aGVHD)的预防效果并初步探索其作用机制。

方法

通过对接受全身辐照的雄性BALB/c小鼠移植雄性C57BL/6小鼠的骨髓细胞和脾脏细胞，构建小鼠异基因造血干细胞移植(allogeneic hematopoietic stem cell transplantation

allo-HSCT)后aGVHD模型，建模部分实验分组：BM组[尾静脉注射500 μL供者C57BL/6小鼠骨髓细胞(5×10

/只)悬液

]

和aGVHD组[尾静脉注射500 μL骨髓细胞(5×10

/只)和脾脏细胞(5×10

/只)混悬液

]

。观察小鼠生存率、临床评分和体质量变化；流式细胞术检测移植后嵌合度；HE染色观察aGVHD靶器官(肺脏、肝脏、结肠、小肠)的病理学改变。收集P4代HUCMSCs，于移植当天混合供者骨髓细胞和脾脏细胞输注BALB/c小鼠，实验分组：①aGVHD组(处理同建模部分)；②aGVHD+MSCs组[经尾静脉注射500 μL骨髓细胞(5×10

/只)、脾脏细胞(5×10

/只)和HUCMSCs(5×10

/只)混悬液

]

。观察HUCMSCs对aGVHD的预防效果，应用ELISA检测各组小鼠血清IFN-γ、TNF-α浓度；流式细胞术检测CD4

T细胞在靶器官中绝对数计数和凋亡水平。

结果

aGVHD组较BM组生存率降低、临床评分增高、体质量减轻明显(

＜0.05)，靶器官病理损伤更为严重(

＜0.05)；移植后小鼠达完全嵌合。HUCMSCs输注显著改善移植后小鼠生存、降低临床评分和靶器官病理损伤(

＜0.05)，并降低血清炎症因子浓度(

＜0.05)，增加CD4

T细胞在靶器官中的凋亡，CD4

T细胞绝对数计数显著下降(

＜0.05)。

结论

HUCMSCs联合allo-HSCT能有效预防及减轻小鼠aGVHD，其作用机制主要是HUCMSCs介导淋巴细胞凋亡，减少其在靶器官中的浸润和调控炎症因子分泌。

Abstract

Objective

To determine the prophylactic effect of human umbilical cord mesenchymal stem cells (HUCMSCs) on murine acute graft-versus-host disease (aGVHD) and preliminarily explore its mechanism.

Methods

In order to establish a mouse model of aGVHD

the male BALB/c mice were transplanted with bone marrow cells and spleen lymphocytes from male C57BL/6 mice after receiving 7.5 Gy total body irradiation (TBI) on the day of allogeneic hematopoietic stem cell transplantation (allo-HSCT). The mice were divided into BM group and aGVHD group

receiving 500 μL cell suspension containing 5×10

bone marrow cells or 5×10

bone marrow cells and 5×10

spleen cells

respectively

by tail vein. Their survival rate

clinical score and loss of body weight were assessed

chimerism was detected by flow cytometry

and pathological changes of target organs (lung

liver

colon

small intestine) were detected by HE staining. The HUCMSCs at passage 4 were collected and transplanted into aGVHD+MSCs group of BALB/c mice. The mice were then divided into aGVHD group (model group)

aGVHD+MSCs group (5×10

bone marrow cells and 5×10

spleen cells and 5×10

HUCMSCs). Besides

the serum concentration of IFN-γ and TNF-α were detected by ELISA

and the infiltration and apoptosis of lymphocytes were detected by flow cytometry.

Results

Compared with the BM group

the aGVHD group showed a decreased survival rate

higher clinical score

and much obvious body weight loss (

0.05) and severer pathological injuries (

0.05). The mice achieved complete chimerism after transplantation. The aGVHD+MSCs group showed increased survival rate

lower clinical score and slighter pathological injuries (

0.05)

the serum concentrations of IFN-γ and TNF-α were decreased (

0.05)

and the apoptosis of CD4

T cells in target organs was increased while the count was decreased (

0.05).

Conclusion

HUCMSCs infusion effectively prevent the development of murine aGVHD after allo-HSCT through mediating the apoptosis of lymphocytes to decrease their infiltration in target organs and regulating the secretion of inflammatory factors.

关键词

Keywords

references

HOU Y C, ZHANG Q W, PANG W J, et al . YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect[J ] . Cell Death Differ, 2021. [Online ahead of print ] . DOI: 10.1038/s41418-021-00804-0..

SUNG A D, CHAO N J. Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment[J]. Stem Cells Transl Med, 2013, 2(1): 25-32. DOI: 10.5966/sctm.2012-0115.

中华医学会血液学分会干细胞应用学组. 中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)——急性移植物抗宿主病(2020年版)[J]. 中华血液学杂志, 2020, 41(7): 529-536. DOI: 10.3760/cma.j.issn.0253-2727.2020.07.001.

Applied Stem Cell Group of Hematology Branch of Chinese Medical Association. Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease(Ⅲ)—acute graft-versus-host disease (2020)[J]. Chin J Hematol, 2020, 41(7): 529-536. DOI: 10.3760/cma.j.issn.0253-2727.2020.07.001.

陈婷, 李小平, 高强国, 等. 不同方法检测急性移植物抗宿主病患者的血清标志物[J]. 第三军医大学学报, 2019, 41(23): 2280-2284. DOI: 10.16016/j.1000-5404.201907252.

CHEN T, LI X P, GAO Q G, et al . Different methods for detecting serum markers in patients with acute graft versus host disease[J ] . J Third Mil Med Univ, 2019, 41(23): 2280-2284. DOI: 10.16016/j.1000-5404.201907252.

RAMACHANDRAN V, KOLLI S S, STROWD L C. Review of graft-versus-host disease[J]. Dermatol Clin, 2019, 37(4): 569-582. DOI: 10.1016/j.det.2019.05.014.

ALADAǦ E, KELKITLI E, GÖKER H. Acute graft-versus-host disease: a brief review[J]. Turk J Haematol, 2020, 37(1): 1-4. DOI: 10.4274/tjh.galenos.2019.2019.0157.

ZAHID M F, LAZARUS H M, RINGDÉN O, et al . Can we prevent or treat graft-versus-host disease with cellular-therapy? [J ] . Blood Rev, 2020, 43: 100669. DOI: 10.1016/j.blre.2020.100669.

FERRARA J L, LEVINE J E, REDDY P, et al . Graft-versus-host disease[J ] . Lancet, 2009, 373(9674): 1550-1561. DOI: 10.1016/S0140-6736(09)60237-3.

MUNNEKE J M, SPRUIT M J, CORNELISSEN A S, et al . The potential of mesenchymal stromal cells as treatment for severe steroid-refractory acute graft-versus-host disease: a critical review of the literature[J ] . Transplantation, 2016, 100(11): 2309-2 314. DOI: 10.1097/tp.0000000000001029.

LE BLANC K, RASMUSSON I, SUNDBERG B, et al . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells[J ] . Lancet, 2004, 363(9419): 1439-1441. DOI: 10.1016/S0140-6736(04)16104-7.

GAO L, ZHANG Y, HU B, et al . Phase Ⅱ multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation[J ] . J Clin Oncol, 2016, 34(24): 2843-2850. DOI: 10.1200/jco.2015.65.3642.

GODOY J A P, PAIVA R M A, SOUZA A M, et al . Clinical translation of mesenchymal stromal cell therapy for graft versus host disease[J ] . Front Cell Dev Biol, 2019, 7: 255. DOI: 10.3389/fcell.2019.00255.

许慧敏, 张素平, 曹伟杰, 等. 人脐带间充质干细胞治疗难治性急性移植物抗宿主病的单臂临床研究[J]. 中国组织工程研究, 2021, 25(31): 4921-4927.

XU H M, ZHANG S P, CAO W J, et al . Human umbilical cord blood-derived mesenchymal stem cells in the treatment of refractory acute graft-versus-host disease: a single-arm clinical study[J ] . Chin J Tissue Eng Res, 2021, 25(31): 4921-4927.

MORATA-TARIFA C, MACÍAS-SÁNCHEZ M D M, GUTIÉRREZ-PIZARRAYA A, et al . Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis[J ] . Stem Cell Res Ther, 2020, 11(1): 64. DOI: 10.1186/s13287-020-01592-z.

NING H, YANG F, JIANG M, et al . The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study[J ] . Leukemia, 2008, 22(3): 593-599. DOI: 10.1038/sj.leu.2405090.

YIP H K, FANG W F, LI Y C, et al . Human umbilical cord-derived mesenchymal stem cells for acute respiratory distress syndrome[J ] . Crit Care Med, 2020, 48(5): e391-e399. DOI: 10.1097/CCM.0000000000004285.

LI H, LIU Q, GAO X F, et al . IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for graft-versus-host disease[J ] . Int J Pharm, 2021, 592: 120058. DOI: 10.1016/j.ijpharm.2020.120058.

WANG R, WANG X Q, YANG S J, et al . Umbilical cord-derived mesenchymal stem cells promote myeloid-derived suppressor cell enrichment by secreting CXCL1 to prevent graft-ver sus-host disease after hematopoietic stem cell transplantation[J ] . Cytotherapy, 2021: S1465-S3249(21)00744-1. DOI: 10.1016/j.jcyt.2021.07.009.

DOMINICI M, LE BLANC K, MUELLER I, et al . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J ] . Cytotherapy, 2006, 8(4): 315-317. DOI: 10.1080/14653240600855905.

COOKE K R, KOBZIK L, MARTIN T R, et al . An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: Ⅰ. the roles of minor H antigens and endotoxin[J ] . Blood, 1996, 88(8): 3230-3239. DOI: 10.1182/blood.V88.8.3230.bloodjournal8883230.

BLAZAR B R, TAYLOR P A, MCELMURRY R, et al . Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer[J ] . Blood, 1998, 92(10): 3949-3959..

TAYLOR P A, LEES C J, BLAZAR B R. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality[J ] . Blood, 2002, 99(10): 3493-3499. DOI: 10.1182/blood.v99.10.3493.

MARTELLI M F, DI IANNI M, RUGGERI L, et al . HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse[J ] . Blood, 2014, 124(4): 638-644. DOI: 10.1182/blood-2014-03-564401.

DU J, PAZ K, THANGAVELU G, et al . Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells[J ] . Blood, 2017, 129(23): 3121-3125. DOI: 10.1182/blood-2016-11-752444.

SIMONETTA F, ALVAREZ M, NEGRIN R S. Natural killer cells in graft-versus-host-disease after allogeneic hematopoietic cell transplantation[J]. Front Immunol, 2017, 8: 465. DOI: 10.3389/fimmu.2017.00465.

LV M, ZHAO X S, HU Y, et al . Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation[J ] . Am J Hematol, 2015, 90(1): E9-E16. DOI: 10.1002/ajh.23865.

ZHOU X Y, JIN N, WANG F, et al . Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease[J ] . Cancer Cell Int, 2020, 20: 114. DOI: 10.1186/s12935-020-01193-z.

MENDT M, DAHER M, BASAR R, et al . Metabolic reprogramming of GMP grade cord tissue derived mesenchymal stem cells enhances their suppressive potential in GVHD[J ] . Front Immunol, 2021, 12: 631353. DOI: 10.3389/fimmu.2021.631353.

MEISEL R, ZIBERT A, LARYEA M, et al . Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation[J ] . Blood, 2004, 103(12): 4619-4621. DOI: 10.1182/blood-2003-11-3909.

VAN DER MAREL A P, SAMSOM J N, GREUTER M, et al . Blockade of IDO inhibits nasal tolerance induction[J ] . J Immunol, 2007, 179(2): 894-900. DOI: 10.4049/jimmunol.179.2.894.

KRAMPERA M, COSMI L, ANGELI R, et al . Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells[J ] . Stem Cells, 2006, 24(2): 386-398. DOI: 10.1634/stemcells.2005-0008.

AKIYAMA K, CHEN C, WANG D D, et al . Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis[J ] . Cell Stem Cell, 2012, 10(5): 544-555. DOI: 10.1016/j.stem.2012.03.007.

PENG Y, CHEN X, LIU Q, et al . Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5 + regulatory B cells producing interleukin 10[J ] . Leukemia, 2015, 29(3): 636-646. DOI: 10.1038/leu.2014.225..

DE WITTE S F H, LUK F, SIERRA PARRAGA J M, et al . Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells[J ] . Stem Cells, 2018, 36(4): 602-615. DOI: 10.1002/stem.2779.

KAIPE H, ERKERS T, SADEGHI B, et al . Stromal cells-are they really useful for GVHD? [J ] . Bone Marrow Transplant, 2014, 49(6): 737-743. DOI: 10.1038/bmt.2013.237.

GALIÈ M, KONSTANTINIDOU G, PERONI D, et al . Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice[J ] . Oncogene, 2008, 27(18): 2542-2551. DOI: 10.1038/sj.onc.1210920.

DU W J, CHI Y, YANG Z X, et al . Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta[J ] . Stem Cell Res Ther, 2016, 7(1): 163. DOI:10.1186/s13287-016- 0418-9.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Curcumin inhibits tumor necrosis factor-α-induced apoptosis of human umbilical cord mesenchymal stem cells in vitro

Efficacy of ursodeoxycholic acid in treatment of early diabetic nephropathy: report of 40 cases

Effects of calcitonin gene-related peptide on osteogenic differentiation of human umbilical cord mesenchymal stem cells

uman umbilical cord mesenchymal stem cell-derived exosomes alleviate renal ischemia/reperfusion injury in rats by regulating SLC7A11/GPX4 pathway

A combined strategy of surface markers for sorting immune cell subsets in patients with chronic graft-versus-host disease

Related Author

Wanjiang WU

Jichao YUAN

Yaxing CHEN

Fei NI

Xin CHEN

Jie WANG

Zexian WEN

Hongyan ZHANG

Related Institution

Department of Neurosurgery, Institute of Neurosurgery, Key Laboratory of Neurotrauma Prevention and Treatment, First Affiliated Hospital, Army Medical University (Third Military Medical University)

Department of Ophthalmology, First Affiliated Hospital, Army Medical University (Third Military Medical University)

Department of Nephrology, Second Affiliated Hospital, Army Medical University (Third Military Medical University)

Department of Endocrinology, Henan Provincial People's Hospital

Department of Stomatology, Second Affiliated Hospital, Army Medical University (Third Military Medical University)

⁰